Could stem cells be the key to saving lives from Sepsis-Induced lung failure?
NCT ID NCT07439848
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tests whether adding umbilical cord stem cells to standard care can help people with severe lung injury (ARDS) caused by pneumonia-related sepsis recover faster and lower their risk of death. About 15 adults aged 40 and older will receive either standard treatment, stem cells, or stem cells plus their secretions. The goal is to see if these treatments improve lung function and reduce hospital stay.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RSPAD Gatot Soebroto
RECRUITINGJakarta Pusat, DKI Jakarta, 10410, Indonesia
Contact
Conditions
Explore the condition pages connected to this study.